Carolyn Bramante

Study from Former KL2 Scholar Shows Metformin Lowers the Risk of Getting Long COVID

In a new study published in The Lancet Infectious Diseases, a team of University of Minnesota researchers found that metformin, a drug commonly used to treat diabetes, prevents the development of long COVID. Former KL2 scholar Carolyn Bramante, MD, is the principal investigator.

Other News

Sara Busche and Adebayo Ibikunle
They have been working with the Mobile Health Initiative to create resource guides and practices to share with providers to use with…
20 Years of HERO
We are filled with profound gratitude and admiration for the incredible work accomplished over the years.
Nhi Lang, Claire Nash, and Margaret Perry
They're working to extrapolate outcome measure data to determine the effectiveness of treatments.